| Literature DB >> 34321815 |
Bedoor AlBloushi1,2, Marco Mura1, Rajiv Khandekar3, Saleh AlMesfer4, Abdulmalik AlYahya1, Khaled Alabduljabbar1, Shaimaa AlRefaie1, Valmore A Semidey1.
Abstract
PURPOSE: To determine the incidence of endophthalmitis after pars plana vitrectomy (PPV), organisms' profile, and management outcomes at a tertiary eye hospital in a Middle East country.Entities:
Keywords: Endophthalmitis; intraocular infection; pars plana vitrectomy
Year: 2021 PMID: 34321815 PMCID: PMC8270018 DOI: 10.4103/meajo.MEAJO_424_20
Source DB: PubMed Journal: Middle East Afr J Ophthalmol ISSN: 0974-9233
Clinical characteristics and vitrectomy features of patients with postvitrectomy endophthalmitis
| Case number | Age (years) | Sex | Systemic disease | Study eye | Indication of vitrectomy | Gauge | Surgical time (min) | Tamponade | Sutured sclerotomy | Interval between surgery and endophthalmitis (days) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 42 | Female | DM | OS | TRD | 23 | 101 | SF6 20% | Yes | 24 |
| 2 | 38 | Male | BA | OS | RRD | 23 | 240 | SO 1000 cs | Yes | 25 |
| 3 | 29 | Male | DM | OD | CTRRD | 23 | 120 | SO 1000 cs | Yes | 3 |
| 4 | 65 | Female | DM, HTN, dyslipidemia | OS | VH | 23 | 30 | Air | Yes | 4 |
| 5 | 2 | Male | Knobloch syndrome | OD | RRD | 23 | 135 | SO 5000 cs | Yes | 23 |
DM: Diabetes mellitus, HTN: Hypertension, BA: Bronchial asthma TRD: Tractional retinal detachment, RRD: Rhegmatogenous retinal detachment, VH: Vitreous hemorrhage, SF6: Sulfur hexafluoride, SO: Silicon oil, cs: Centistokes, CTRRD: Combined tractional/rhegmatogenous retinal detachment, OS: Oculus sinister, OD: Oculus dextrus
Culture growth
| Frequency (%) | Valid percent | |
|---|---|---|
| Valid | ||
| No growth | 1 (20.0) | 25.0 |
| Growth | 3 (60.0) | 75.0 |
| Total | 4 (80.0) | 100.0 |
| Missing | 1 (evisceration) (20.0) | |
| Total | 100.0 |
Culture results, site of positive culture, visual acuity and anatomical outcomes
| Case number | Organism | Culture site | Initial management | Dexamethasone | Surgery required | VA before initial vitrectomy VA | BCVA at presentation | BCVA final | Follow-up period (months) | Retina condition |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | - | - | - | - | Evisceration | 4/200 | NLP | Evisceration | 48 | Evisceration |
| 2 | Vitreous | V + C | No | PPV | 20/100 | HM | 20/400 | 24 | Attached | |
| 3 | AC | V + C | No | None | 20/40 | HM | HM | 36 | Attached | |
| 4 | Vitreous | V + C | No | PPV + PPL | HM | NLP | NLP | 6 | Attached | |
| 5 | No growth | AC | V + C | Yes | PPV | FF | - | Phthisis | 12 | Detached |
AC: Anterior chamber. PPV: Pars plana vitrectomy, PPL: Pars plana lensectomy. V + C: Vancomycin + ceftazidime, S. epidermidis: Staphylococcus epidermidis, VA: Visual acuity, HM: Hand motion, NLP: No light perception, BCVA: Best corrected visual acuity, CF: Counting finger
Culture positivity of micro incision postvitrectomy endophthalmitis
| Study (years) | Percentage with positive culture (%) |
|---|---|
| Oshima | 63 |
| Scott | 66.6 |
| Wu | 62.5 |
| Dave | 55 |
| Lin | 66.6 |
| Current Study | 75 |